Angewandte
Chemie
DOI: 10.1002/anie.201304281
Kinetic Resolution
Kinetic Resolution of Secondary Alcohols Catalyzed by Chiral
Phosphoric Acids**
Shingo Harada, Satoru Kuwano, Yousuke Yamaoka, Ken-ichi Yamada,* and Kiyosei Takasu*
Of the many methods to separate enantiomeric constituents
from racemic materials, kinetic resolution offers distinct
advantages, especially when a chiral catalyst is involved.
Kinetic resolution of racemic alcohols by esterification is an
important process in synthetic chemistry, and many artificial
catalysts as well as enzymatic methods have been developed
for this purpose.[1] Their catalytic mechanisms are classified
into two types: 1) Enhancement of the nucleophilicity of
alcohols as a metal alkoxide bearing a chiral ligand[2]
(Scheme 1, class a); and 2) in situ generation of chiral
acylating reagents by nucleophilic chiral organocatalysts[3]
(Scheme 1, class b).[4]
Scheme 2. cis-2-Arylcycloalkanol motifs in bioactive compounds.
Although Brønsted acids promote the acylation of
alcohols with an acid anhydride,[12] a systematic study of
their catalytic activity has not been reported. At the outset of
this study, several Brønsted acids were tested in the acylation
of cis-2-phenylcyclohexanol (5a) with isobutyric anhydride
(6a).[13] Acylation did not occur in chloroform at ambient
temperature after 24 h in the absence or presence of
isobutyric acid. In contrast, stronger acids, such as phosphoric
acid, accelerated acylation. With highly acidic triflic imide,
acylation was complete within 0.5 h with only 0.5 mol% of the
catalyst. These results show that isobutyric acid does not
Scheme 1. Activation and enantiomer-discrimination modes in acyla-
tion-based kinetic resolution of secondary alcohols.
catalyze background acylation to give a racemic product, but
an appropriately strong acid catalyzes acylation from 6a in
accordance to the acid strength of the catalyst.
As a new mechanistic class, we expect that a chiral
Brønsted acid will activate the acylating agent by hydrogen
bonding and simultaneously discriminate the enantiomers of
alcohols (Scheme 1, class c).[5] Herein we present the first
kinetic resolution of secondary alcohols by chiral phosphoric
acid catalyzed acylation.[6] This method provides effective
access to optically pure 2-arylcycloalkanols,[7] which are
structural motifs of biologically significant compounds, such
as lycorine (1),[8] epicatechin (2),[9] PF-998,425 (3),[10] and L-
733,060 (4)[11] (Scheme 2).
Since the pioneering work of Akiyama and Terada,[14]
chiral phosphoric acids have emerged as powerful Brønsted
acid catalysts for various organic transformations.[15] How-
ever, acylation reactions catalyzed by this type of catalyst
have rarely been reported.[6] Nevertheless, in the presence of
chiral phosphoric acid (R)-TRIP (7a)[16,17] (5 mol%), a solu-
tion of (Æ)-5a and 6a (1.5 equiv) in chloroform was stirred at
ambient temperature. Acylation proceeded slowly, and
reached 47% conversion after 48 h to give (+)-8aa with
good enantioselectivity (s = 24;[18] Table 1, entry 1). Although
the reaction was greatly accelerated (41–64% conversion
after 0.5–5 h) using more acidic 7b–7d, the selectivity
decreased (s = 1–17; entries 2–4). TRIP-based phosphoric
acid 7e,[19] which bore bromine atoms at the 6,6’-positions,
enhanced the selectivity as well as the reaction rate (s = 45,
50% conversion after 24 h; entry 5). Finally, a new catalyst 7 f,
which had nitro groups at the 6,6’-positions, was the best
catalyst, exhibiting a sufficient s value and reaction rate (s =
110, 32% conversion after 5 h; entry 6). Even with
a decreased amount of 6a (0.7 equiv), the reaction with
catalyst 7 f proceeded with a similar selectivity (s = 113) and
reached 51% conversion after 24 h (entry 7).[13]
[*] Dr. S. Harada, S. Kuwano, Dr. Y. Yamaoka, Prof. Dr. K. Yamada,
Prof. Dr. K. Takasu
Graduate School of Pharmaceutical Sciences, Kyoto University
Yoshida, Sakyo-ku, Kyoto 606-8501 (Japan)
E-mail: yamak@pharm.kyoto-u.ac.jp
[**] We thank MEXT (Japan) for financial support (Grants-in-Aid for
Scientific Research and Platform for Drug Design, Discovery, and
Development).
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2013, 52, 1 – 5
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!